Clinical Trials Browser

Phase 3 × inavolisib × 90 days × Clear all

NCT05862285 2026-03-13

UmbrellaMAX

Phase 3 Recruiting

Neoplasms

NCT06790693 2026-03-06

INAVO123

Phase 3 Recruiting

Breast Neoplasms

NCT05646862 2026-02-05

INAVO121

Phase 3 Active not recruiting

Breast Neoplasms